{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ctDNA+Testing&page=2", "query": { "intervention": "ctDNA Testing", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ctDNA+Testing&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-02T17:10:45.489Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07399977", "title": "Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Venous Thromboembolism", "Deep Venous Thrombosis" ], "interventions": [ { "name": "MSK-ACCESS", "type": "DIAGNOSTIC_TEST" }, { "name": "ctDNA/VTE Risk Score:", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 259, "start_date": "2026-01-30", "completion_date": "2030-01-30", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07399977" }, { "nct_id": "NCT07793240", "title": "Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Cancer (UTUC)", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Upper Tract Urothelial Carcinoma" ], "interventions": [ { "name": "Signatera testing", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2026-10-01", "completion_date": "2029-10-01", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07793240" }, { "nct_id": "NCT05733689", "title": "Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gastroesophageal Adenocarcinoma" ], "interventions": [ { "name": "FLOT", "type": "COMBINATION_PRODUCT" }, { "name": "FOLFOX", "type": "COMBINATION_PRODUCT" }, { "name": "FOLFIRI", "type": "COMBINATION_PRODUCT" }, { "name": "FOLFIRINOX", "type": "COMBINATION_PRODUCT" }, { "name": "PACLITAXEL with or without CARBOPLATIN", "type": "COMBINATION_PRODUCT" }, { "name": "DOCETAXEL and IRINOTECAN (alone or combined)", "type": "COMBINATION_PRODUCT" }, { "name": "NIVOLUMAB (alone or when added to a regimen above)", "type": "DRUG" }, { "name": "PEMBROLIZUMAB (alone or when added to a regimen above)", "type": "DRUG" }, { "name": "Durvalumab", "type": "DRUG" }, { "name": "Trastuzumab", "type": "DRUG" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "University of California, Irvine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2025-06-27", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05733689" }, { "nct_id": "NCT05287347", "title": "Panc CA Risk Model & Biomarker Testing In High-Risk Cohort", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pancreatic Adenocarcinoma" ], "interventions": [ { "name": "Blood Specimen", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "50 Years to 100 Years" }, "enrollment_count": 0, "start_date": "2022-01-01", "completion_date": "2024-12-03", "has_results": false, "last_update_posted_date": "2025-05-25", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05287347" }, { "nct_id": "NCT01775072", "title": "Genomic Profiling in Cancer Patients", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Solid Tumors", "Hematologic Cancers" ], "interventions": [ { "name": "molecular profiling of tumors", "type": "GENETIC" }, { "name": "Clinical Germline Analysis", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 200, "start_date": "2013-01", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 18, "location_summary": "Bridgeport, Connecticut • Hartford, Connecticut • Norwalk, Connecticut + 13 more", "locations": [ { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Norwalk", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Basking Ridge", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01775072" }, { "nct_id": "NCT05221827", "title": "Clinical Performance Evaluation of the C2i-Test", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Muscle-Invasive Bladder Carcinoma" ], "interventions": [ { "name": "C2i Test", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "C2i Genomics", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "22 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "22 Years to 100 Years" }, "enrollment_count": 3, "start_date": "2022-02-24", "completion_date": "2022-07-27", "has_results": false, "last_update_posted_date": "2023-02-27", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 1, "location_summary": "Bloomfield, New Jersey", "locations": [ { "city": "Bloomfield", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05221827" }, { "nct_id": "NCT04585490", "title": "Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non Small Cell Lung Cancer", "NSCLC, Stage III", "Nsclc" ], "interventions": [ { "name": "Durvalumab", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "AVENIO ctDNA Surveillance Kit", "type": "DEVICE" }, { "name": "Tremelimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Maximilian Diehn", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2021-08-25", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-05-04", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04585490" }, { "nct_id": "NCT06663787", "title": "Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Patients Who Achieved Durable Response to Anti-HER2 Treatment", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer, Metastatic", "HER2 + Breast Cancer" ], "interventions": [ { "name": "Trastuzumab (Herceptin)", "type": "DRUG" }, { "name": "SIgnatera", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Nagoya City University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Years", "maximum_age": null, "sex": "FEMALE", "summary": "20 Years and older · Female only" }, "enrollment_count": 50, "start_date": "2024-04-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 1, "location_summary": "San Carlos, Texas", "locations": [ { "city": "San Carlos", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06663787" }, { "nct_id": "NCT06736613", "title": "A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diffuse Large B Cell Lymphoma", "High-grade B-cell Lymphoma", "Stage III High Grade B-Cell Lymphoma", "Stage IV High Grade B-Cell Lymphoma", "DLBCL - Diffuse Large B Cell Lymphoma", "Intravascular Large B-Cell Lymphoma", "Diffuse Large B Cell Lymphoma of Breast", "Diffuse Large B Cell Lymphoma of Testis", "HIV-associated Diffuse Large B Cell Lymphoma", "Double Expressor DLBCL" ], "interventions": [ { "name": "Cerebral Spinal Fluid ctDNA", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2024-12-11", "completion_date": "2027-12-11", "has_results": false, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06736613" }, { "nct_id": "NCT06589310", "title": "Falcon Real World Evidence Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer" ], "interventions": [ { "name": "Exact Sciences Multicancer Early Detection (MCED) Test", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Exact Sciences Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "50 Years to 80 Years" }, "enrollment_count": 25000, "start_date": "2024-08-01", "completion_date": "2031-01", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-09-02T17:10:45.489Z", "location_count": 2, "location_summary": "Evanston, Illinois • Dallas, Texas", "locations": [ { "city": "Evanston", "state": "Illinois" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06589310" } ] }